Hamid R Nasiri

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Candida Albicans

Human Immunodeficiency Virus

Structure Activity Relationship

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Kägi, Willough Sloan, Johannes Schimpf, Hamid R Nasiri, Dana Lashley, Thorsten Friedrich
Exploring ND-011992, a quinazoline-type inhibitor targeting quinone reductases and quinol oxidases. Scientific reports 13 (1) (2023)
Zhenyu Han, Heike Angerer, Iris Bischoff, Yihan Qin, Dennis Stegmann, Karina Tuz, Günter Fritz, Oscar Juarez, Robert Fürst, Dana Lashley, Hamid R Nasiri
Concise Synthesis of 1,4-Benzoquinone-Based Natural Products as Mitochondrial Complex I Substrates and Substrate-Based Inhibitors. ChemMedChem 15 (24) (2020)
Robin Krishnathas, Erik Bonke, Stefan Dröse, Volker Zickermann, Hamid R Nasiri
Identification of 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine as a novel, highly potent and specific inhibitor of mitochondrial complex I. MedChemComm 8 (3) (2017)
Hamid R Nasiri, Philipp Mracek, Steffen K Grimm, Janine Gastaldello, Adrian Kolodzik, Dirk Ullmann
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B. MedChemComm 8 (6) (2017)